XML 30 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments (Tables)
12 Months Ended
Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease commitments

The Company has entered into an office lease agreement expiring March 31, 2019. The Company is committed to lease commitments as follows:

 

Fiscal year ending September 30, 2019     $ 70,022  
      $ 70,022  
Schedule of share purchase warrants

A summary of the status of the Company’s outstanding share purchase warrants is presented below:

  

      Number of Shares     Weighted Average Exercise Price  
               
Balance, October 1, 2015       4,272,890     $ 2.11  
Exercised       (2,463,581 )   $ 1.67  
Balance, September 30, 2016       1,809,309     $ 2.70  
Exercised       (200,000 )   $ 3.00  
Balance,September 30, 2017       1,609,309     $ 2.66  
Issued       350,000     $ 4.19  
Exercised       (756,143 )   $ 2.96  
Expired       (524,787 )   $ 3.00  
Balance, September 30, 2018       678,379     $ 2.87  

 

At September 30, 2018, the Company had 678,379 share purchase warrants outstanding, with a weighted average exercise price of $2.87 as follows:

 

Number     Exercise Price     Expiry Date
30,000     $ 4.00     February 24, 2019
277,127     $ 1.20     March 13, 2019
1,252     $ 1.68     March 13, 2019
12,500     $ 1.24     May 31, 2019
7,500     $ 1.04     May 31, 2019
350,000     $ 4.19     June 30, 2021
678,379              
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

  

      Number of Shares     Weighted Average Exercise Price     Weighted Average Grant Date Fair Value  
Outstanding at October 1, 2015       1,822,500     $ 2.00          
Granted       2,401,500       5.22     $ 4.38  
Expired       (25,000 )     14.68          
Outstanding at September 30, 2016       4,199,000       3.76          
Granted       1,107,500       5.51     $ 5.44  
Forfeited       (214,470 )     4.09          
Outstanding at September 30, 2017       5,092,030     $ 4.13          
Granted       1,730,000     $ 2.71     $ 2.09  
Forfeited       (164,280 )   $ 3.66          
Exercised       (150,833 )   $ 1.18          
Outstanding at September 30, 2018       6,506,917     $ 3.83          
Exercisable at September 30, 2018       4,108,028     $ 3.75          
Exercisable at September 30, 2017       3,326,223     $ 3.10          
Schedule of stock options outstanding

At September 30, 2018, the following stock options were outstanding:

  

Number of Shares               Aggregate     Remaining  
      Number     Exercise         Intrinsic     Contractual  
Total     Vested     Price     Expiry Date   Value     Life (yrs)  
  500,000       500,000     $ 1.60     July 5, 2023   $ 565,000       4.76  
  37,500       37,500     $ 1.20     May 7, 2024     57,375       5.60  
  125,000       125,000     $ 1.32     May 8, 2024     176,250       5.60  
  618,750       618,750     $ 0.92     April 2, 2025     1,119,938       6.51  
  29,167       29,167     $ 1.44     June 8, 2025     37,625       6.69  
  50,000       50,000     $ 1.76     June 15, 2025     48,500       6.71  
  253,750       253,750     $ 5.04     September 18, 2025           6.97  
  1,500       1,500     $ 5.64     September 30, 2025           7.00  
  31,250       31,250     $ 5.68     October 2, 2025           7.01  
  25,000       25,000     $ 8.98     October 16, 2025           7.04  
  1,500       1,500     $ 5.57     December 31, 2025           7.25  
  1,500       1,500     $ 4.90     March 31, 2026           7.50  
  1,500       1,500     $ 5.66     April 27, 2026           7.57  
  1,500       1,500     $ 6.11     June 30, 2026           7.75  
  379,625       253,083     $ 6.26     July 5, 2026           7.76  
  861,429       574,286     $ 7.06     July 18, 2026           7.80  
  906,696       906,696     $ 3.28     September 22, 2026           7.98  
  60,000       39,999     $ 3.63     October 3, 2026           8.01  
  8,750       8,750     $ 4.35     December 9, 2026           8.19  
  50,000       16,667     $ 5.39     February 7, 2027           8.36  
  40,000       23,333     $ 5.26     February 17, 2027           8.38  
  774,166       389,170     $ 5.92     May 12, 2027           8.61  
  12,500       5,209     $ 3.42     August 9, 2027           8.86  
  15,000       6,250     $ 4.33     September 19, 2027           8.97  
  540,834       135,834     $ 3.30     December 13, 2027           9.20  
  50,000           $ 2.60     March 2, 2028     6,500       9.42  
  200,000       33,334     $ 2.72     March 19, 2028     2,000       9.47  
  780,000       25,000     $ 2.30     May 15, 2028     335,400       9.62  
  150,000       12,500     $ 2.70     August 6, 2028     4,500       9.85  
  6,506,917       4,108,028                 $ 2,353,088          
Schedule of statement of operations

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows:

  

    2018     2017     2016  
General and administrative   $ 2,699,557     $ 2,017,199     $ 3,208,220  
Research and development     2,817,447       2,118,371       1,854,047  
Total share based compensation   $ 5,517,004     $ 4,135,570     $ 5,062,267  
Schedule of weighted average assumptions

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

 

    2018     2017     2016  
Risk-free interest rate     2.73 %     2.11 %     1.28 %
Expected life of options (years)     5.60       6.86       5.88  
Annualized volatility     106.45 %     111.58 %     114.75 %
Dividend rate     0.00 %     0.00 %     0.00 %